These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 23735957)
1. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage. Etminan N; Beseoglu K; Eicker SO; Turowski B; Steiger HJ; Hänggi D Stroke; 2013 Aug; 44(8):2162-8. PubMed ID: 23735957 [TBL] [Abstract][Full Text] [Related]
2. The effect of intraventricular thrombolysis in combination with low-frequency head motion after severe subarachnoid hemorrhage: interim analysis of safety, clot clearance rate and delayed cerebral ischemia. Eicker SO; Beseoglu K; Etminan N; Perrin J; Taskin A; Steiger HJ; Hänggi D Acta Neurochir Suppl; 2012; 114():323-8. PubMed ID: 22327716 [TBL] [Abstract][Full Text] [Related]
3. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Findlay JM; Jacka MJ Neurosurgery; 2004 Sep; 55(3):532-7; discussion 537-8. PubMed ID: 15335420 [TBL] [Abstract][Full Text] [Related]
4. FIVHeMA: Intraventricular fibrinolysis versus external ventricular drainage alone in aneurysmal subarachnoid hemorrhage: A randomized controlled trial. Gaberel T; Gakuba C; Fournel F; Le Blanc E; Gaillard C; Peyro-Saint-Paul L; Chaillot F; Tanguy P; Parienti JJ; Emery E Neurochirurgie; 2019 Feb; 65(1):14-19. PubMed ID: 30638547 [TBL] [Abstract][Full Text] [Related]
5. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial. Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207 [TBL] [Abstract][Full Text] [Related]
6. The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial. Hänggi D; Liersch J; Turowski B; Yong M; Steiger HJ J Neurosurg; 2008 Jun; 108(6):1192-9. PubMed ID: 18518727 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis. Staykov D; Kuramatsu JB; Bardutzky J; Volbers B; Gerner ST; Kloska SP; Doerfler A; Schwab S; Huttner HB Ann Neurol; 2017 Jan; 81(1):93-103. PubMed ID: 27888608 [TBL] [Abstract][Full Text] [Related]
8. Intraventricular fibrinolysis has no effects on shunt dependency and functional outcome in endovascular-treated aneurysmal SAH. Gerner ST; Kuramatsu JB; Abel H; Kloska SP; Lücking H; Eyüpoglu IY; Doerfler A; Schwab S; Huttner HB Neurocrit Care; 2014 Dec; 21(3):435-43. PubMed ID: 24566979 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage. Yamamoto T; Esaki T; Nakao Y; Mori K World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155 [TBL] [Abstract][Full Text] [Related]
10. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain. Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository. Jaja BN; Lingsma H; Schweizer TA; Thorpe KE; Steyerberg EW; Macdonald RL; J Neurosurg; 2015 Mar; 122(3):644-52. PubMed ID: 25554825 [TBL] [Abstract][Full Text] [Related]
13. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Huttner HB; Tognoni E; Bardutzky J; Hartmann M; Köhrmann M; Kanter IC; Jüttler E; Schellinger PD; Schwab S Eur J Neurol; 2008 Apr; 15(4):342-9. PubMed ID: 18312407 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and safety of intraventricular fibrinolysis in secondary intraventricular hemorrhages (a prospective, randomized study)]. Gubucz I; Kakuk I; Major O; Szegedi N; Barsi P; Pánczél G; Varga D; Ovary C; May Z; Ricsói G; Kenéz J; Szilágyi G; Nagy Z Orv Hetil; 2004 Aug; 145(31):1609-15. PubMed ID: 15384858 [TBL] [Abstract][Full Text] [Related]